Testosterone products are approved by the US Food and Drug Administration (FDA) as
replacement therapy for men with classical androgen deficiency (ie men with very low serum …

Androgen deprivation therapy (ADT) is part of standard therapy for locally advanced or
metastatic prostate cancer and is frequently used in men with a rising prostate-specific …

Male Hypogonadism: A Review - Marco Marcelli, Sanjay Navin Mediwala, 2020 Skip to
main content Intended for healthcare professionals SAGE Journals Home Search this …

A double-blind comparison was made of the effects of testosterone undecanoate (TU) and
placebo on sexual potency of 29 impotent men ages 45–75. The main criteria for inclusion in …

Introduction Androgen deprivation therapy (ADT) is commonly utilized in the management of
both localized and advanced adenocarcinoma of the prostate. The use of ADT is associated …

Background The benefits and risks of testosterone treatment for women with diminished
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …

Methods The current guideline is structured as a series of questions & answers (Q&A)
relating to the diagnosis and management of TD. By way of this structure, the guideline …

Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer:
Current Evidence and Recommendations for the Clinician - ScienceDirect Skip to main …

Hypogonadism in men has a complex and varied pathogenesis. In addition to multiple
established causes of the disease, low testosterone levels are associated with various …

Introduction: Androgen deprivation therapy (ADT) for advanced prostate cancer can be
associated with side effects which may negatively impact quality of life (QoL) and induce …